371 related articles for article (PubMed ID: 15639702)
1. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
Daley-Yates PT; Richards DH
Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009471. PubMed ID: 25030198
[TBL] [Abstract][Full Text] [Related]
3. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
Selroos O; Halme M
Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
[TBL] [Abstract][Full Text] [Related]
4. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ
Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
[TBL] [Abstract][Full Text] [Related]
5. Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
[TBL] [Abstract][Full Text] [Related]
6. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.
Daley-Yates PT; Price AC; Sisson JR; Pereira A; Dallow N
Br J Clin Pharmacol; 2001 May; 51(5):400-9. PubMed ID: 11421996
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
Axelsson I; Naumburg E; Prietsch SO; Zhang L
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010126. PubMed ID: 31194879
[TBL] [Abstract][Full Text] [Related]
8. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR
Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
[TBL] [Abstract][Full Text] [Related]
9. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.
Lipworth BJ; Jackson CM
Drug Saf; 2000 Jul; 23(1):11-33. PubMed ID: 10915030
[TBL] [Abstract][Full Text] [Related]
10. Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices.
Trescoli C; Ward MJ
Postgrad Med J; 1998 Nov; 74(877):675-7. PubMed ID: 10197215
[TBL] [Abstract][Full Text] [Related]
11. The relationship between fluticasone furoate systemic exposure and cortisol suppression.
Allen A
Clin Pharmacokinet; 2013 Oct; 52(10):885-96. PubMed ID: 23719680
[TBL] [Abstract][Full Text] [Related]
12. Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis.
Shaikh WA
J Investig Allergol Clin Immunol; 1999; 9(1):45-9. PubMed ID: 10212857
[TBL] [Abstract][Full Text] [Related]
13. Impact of inhaled and intranasal corticosteroids on the growth of children.
Wolthers OD
BioDrugs; 2000 May; 13(5):347-57. PubMed ID: 18034541
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
16. Assessing the effect of intranasal steroids on growth.
Pedersen S
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S40-4. PubMed ID: 11449205
[TBL] [Abstract][Full Text] [Related]
17. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
[TBL] [Abstract][Full Text] [Related]
18. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
19. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
